| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amgen Inc (AMGN) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. AMGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 505.2K | $174.14M | - | |
| VP | 83.4K | $28.74M | - | |
| VP | 51.2K | $17.66M | - | |
| CFO | 50.7K | $17.48M | - | |
| VP | 42.8K | $14.76M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2019 | Williams R Sanders54 | Director | Sell | 425 | $183.04 | $77,792.00 | -6.8% | |
| Aug 7, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $183.04 | $366,080.00 | -12.2% | |
| Jul 3, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $187.58 | $375,160.00 | -12.2% | |
| Jun 5, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $175.68 | $351,360.00 | -12.3% | |
| May 1, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $175.73 | $351,460.00 | -13.3% | |
| Apr 3, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $193.18 | $386,360.00 | -13.3% | |
| Mar 6, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $188.88 | $377,760.00 | -13.3% | |
| Feb 7, 2019 | Sugar Ronald D | Director | Sale+OE | 2,000 | $190.00 | $380,000.00 | -13.3% | |
| Dec 6, 2018 | Jacks Tyler | Director | Sale+OE | 20,000 | $195.41 | $3,908,232.00 | -69.0% | |
| Nov 29, 2018 | Patton Cynthia M | SVP &CCO | Sale+OE | 1,777 | $202.88 | $360,519.89 | -7.7% |